Palliative sedation in a southern appalachian community

American Journal of Hospice and Palliative Medicine

Volumn 23, Issue 5, 2006, Pages 360-368

  Cowan, John D ^a   Clemens, Libby ^a   Palmer, Teresa ^a  

^a BLOUNT MEMORIAL HOSPITAL   (United States)

Author keywords

Community palliative care; Palliative sedation; Refractory symptoms

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONSCIOUS SEDATION; DRUG USE; DYSPNEA; FAMILY; FEMALE; FOLLOW UP; HEALTH SERVICES RESEARCH; HUMAN; LUNG DISEASE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NEOPLASM; PAIN; PALLIATIVE THERAPY; PATIENT SELECTION; PRESCRIPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; UNITED STATES;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; CONSCIOUS SEDATION; DRUG UTILIZATION REVIEW; DYSPNEA; FAMILY; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES RESEARCH; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PALLIATIVE CARE; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; TENNESSEE;

EID: 34247199610     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909106292173     Document Type: Article

References (38)

1. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Palliat Med. 1998;12:255-269.
2. Cowan JD, Palmer T. Practical guide to palliative sedation. Curr Oncol Rep. 2002;4:242-249.
3. Cowan JD, Walsh D. Terminal sedation in palliative medicine- definition and review of the literature. Support Care Cancer. 2001;9:403-407.
4. Enck RE. Drug-induced terminal sedation for symptom control. Am J Hosp Palliat Care. 1991;8:3-5.
5. Fainsinger RL, Waller A, Bercovici M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med. 2000;14:257-265.
6. Furst CJ, Doyle D. The terminal phase. In: Doyle D, Hanks G, Cherny NI, Calman KCB, eds. Oxford Textbook of Palliative Medicine. 3rd ed. New York, NY: Oxford University Press; 2005:1119-1133.
7. Kohara H, Ueoka J, Takeyama H, Murakami T, Morita T. Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med. 2005;8:20-25.
8. Krakauer EL, Penson RT, Truog RD, King LA, Chabner BA, Lynch TJ Jr. Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist. 2000;5:53-62.
9. Lynch M. Palliative sedation. Clin J Oncol Nurs. 2003;7:653-667.
10. Morita T, Tsunoda J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death? J Palliat Care. 1999;15:20-23.
11. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria, J Pain Symptom Manage. 2002;24:447-453.
12. Rousseau P. Palliative sedation in the control of refractory symptoms. J Palliat Med. 2005;8:10-12.
13. Storey P. Symptom control in dying. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and Practice of Supportive Oncology. Philadelphia, PA: Lippincott-Raven; 1998:741-748.
14. Cherny NI. The use of sedation in the management of refractory pain. Prin Pract Support Oncol Updates. 2000;3:1-11.
15. Cherney NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care. 1994;10:31-38.
16. Chiu T, Hu W, Lue B, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage. 2001;21:467-472.
17. Fainsinger RL. Use of sedation by a hospital palliative care support team. J Palliat Care. 1998;14:51-54.
18. Fainsinger RL, de Moissac D, Mancini I, Oneschuk D. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care. 2000;16:5-10.
19. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7:5-11.
20. Hardy J. Sedation in terminally ill patients. Lancet. 2000;356:1866-1867.
21. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:7-15.
22. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage. 1996;12:32-38.
23. Muller-Bush HC, Andrs I, Jehser T. Sedation in palliative care - a critical analysis of 7 years experience. BMC Palliative Care. 2003;2:2-10.
24. Rousseau P. Existential suffering and palliative sedation: a brief commentary with a proposal for clinical guidelines. Am J Hosp Palliat Care. 2001;18:151-153.
25. Rousseau P. The ethical validity and clinical experience of palliative sedation. Mayo Clin Proc. 2000;75:1064-1069.
26. Ventafridda V, Ripamonti C, de Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care. 1990;6:7-11.
27. Cowan JD, Burns D, Palmer TW, et al. A palliative medicine program in a community setting: 12 points from the first 12 months. Am J Hosp Palliat Care. 2003;20:415-433.
28. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J. 1991;84:332-337.
29. Emanuel LL, von Gunten, CF, Ferris FD. Plenary 1: Gaps in end-of-life care. The Education for Physicians on End-of-Life Care (EPEC) Curriculum. Princeton, NJ: The Robert Wood Johnson Foundation; 1999:1-5-1-8.
30. Cowan JD, Walsh D, Homsi J. Palliative medicine in a United States cancer center. A prospective study. Am J Hosp Palliat Care. 2002;19:240-250.
31. Breitbart W, Chochinov HM, Passik S. Psychiatric symptoms in palliative medicine. In: Doyle D, Hanks G, Cherny NI, Calman KCB, eds. Oxford Textbook of Palliative Medicine. 3rd ed. New York, NY: Oxford University Press; 2005:746-771
32. Goodwin M. Potentiating the problem of delirium? Crit Care Nurse. 2003;23:13.
33. Ingham JM, Caraceni AT. Delirium. In: Berger AM, Portenoy RK, Weissman DE, editors, Principles and Practice of Supportive Oncology. Philadelphia, PA: Lippincott-Raven; 1998:477-495.
34. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage. 1994;9:341-345.
35. McNamara P, Minton M, Twycross RG. Use of midazolam in palliative care. Palliat Med. 1991;5:244-249.
36. Stone P, Phillips C, Spruyt O. Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med. 1997;11:140-144.
37. Morita T, Bito S, Kurihara Y, Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med. 2005;8:716-729.
38. Taylor BK, McCann RM. Controlled sedation for physical and existential suffering? J Palliat Med. 2005;8:144-147